London
· Delayed Price · Currency is GBP · Price in USD Heron Therapeutics Statistics
Total Valuation
LON:0J4V has a market cap or net worth of GBP 265.10 million. The enterprise value is 353.59 million.
| Market Cap | 265.10M |
| Enterprise Value | 353.59M |
Important Dates
The next estimated earnings date is Friday, May 9, 2025.
| Earnings Date | May 9, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +10.36% |
| Shares Change (QoQ) | +0.21% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 115.92M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.30 |
| PB Ratio | -9.86 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -32.60 |
| EV / Sales | 3.28 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -18.27 |
Financial Position
The company has a current ratio of 2.29
| Current Ratio | 2.29 |
| Quick Ratio | 1.51 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -7.33 |
| Interest Coverage | -1.91 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -3.16% |
| Return on Invested Capital (ROIC) | -4.97% |
| Return on Capital Employed (ROCE) | -8.14% |
| Revenue Per Employee | 944,676 |
| Profits Per Employee | -88,912 |
| Employee Count | 122 |
| Asset Turnover | 0.63 |
| Inventory Turnover | 1.16 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -11.14% in the last 52 weeks. The beta is 1.40, so LON:0J4V's price volatility has been higher than the market average.
| Beta (5Y) | 1.40 |
| 52-Week Price Change | -11.14% |
| 50-Day Moving Average | 2.11 |
| 200-Day Moving Average | 1.98 |
| Relative Strength Index (RSI) | 58.98 |
| Average Volume (20 Days) | 18,650 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 19.79 |
Income Statement
In the last 12 months, LON:0J4V had revenue of GBP 115.25 million and -10.85 million in losses. Loss per share was -0.07.
| Revenue | 115.25M |
| Gross Profit | 71.05M |
| Operating Income | -9.21M |
| Pretax Income | -10.85M |
| Net Income | -10.85M |
| EBITDA | -7.22M |
| EBIT | -9.21M |
| Loss Per Share | -0.07 |
Balance Sheet
The company has 47.35 million in cash and 141.99 million in debt, giving a net cash position of -94.64 million.
| Cash & Cash Equivalents | 47.35M |
| Total Debt | 141.99M |
| Net Cash | -94.64M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | -26.88M |
| Book Value Per Share | -0.18 |
| Working Capital | 93.90M |
Cash Flow
In the last 12 months, operating cash flow was -18.00 million and capital expenditures -1.36 million, giving a free cash flow of -19.36 million.
| Operating Cash Flow | -18.00M |
| Capital Expenditures | -1.36M |
| Free Cash Flow | -19.36M |
| FCF Per Share | n/a |
Margins
Gross margin is 61.65%, with operating and profit margins of -7.99% and -9.41%.
| Gross Margin | 61.65% |
| Operating Margin | -7.99% |
| Pretax Margin | -9.41% |
| Profit Margin | -9.41% |
| EBITDA Margin | -6.26% |
| EBIT Margin | -7.99% |
| FCF Margin | n/a |
Dividends & Yields
LON:0J4V does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -10.36% |
| Shareholder Yield | -10.36% |
| Earnings Yield | -4.09% |
| FCF Yield | -7.30% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
LON:0J4V has an Altman Z-Score of -9.65. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -9.65 |
| Piotroski F-Score | n/a |